RTI Surgical (RTIX) Stock Price, News & Analysis

Company Overview

Surgalign Holdings, Inc. is a global medical technology company, which engages in designing, developing and manufacturing biologic metal and synthetic implants worldwide. It focuses on delivering spine solutions that drive clinical and economic outcomes. The company markets its products throughout the United States and other countries worldwide through an expanding network of independent distributors. The company was founded in February 1998 and is headquartered in Deerfield, IL.

Key Stats

• Today's Range: $3.12 to $3.30
• 50-Day Range: $3.14 to $3.14
• 52-Week Range: $1.46 to $5.40
• Volume: 686,036 shs
• Average Volume: 622,541 shs
• Market Capitalization: $234.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RTIX Stock Analysis - Frequently Asked Questions

How were RTI Surgical's earnings last quarter?

RTI Surgical Holdings, Inc. (NASDAQ:RTIX) posted its quarterly earnings results on Tuesday, June, 30th. The medical equipment provider reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.04. The medical equipment provider had revenue of $73.73 million for the quarter.

What other stocks do shareholders of RTI Surgical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that RTI Surgical investors own include LightPath Technologies (LPTH), EXFO (EXFO), TherapeuticsMD (TXMD), Merit Medical Systems (MMSI), Pfizer (PFE), Anixa Biosciences (ANIX) and Ampio Pharmaceuticals (AMPE).

Company Calendar

• Last Earnings: 6/30/2020
• Today: 4/22/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical Appliances & Supplies
• Sub-Industry: Health Care Supplies
• Current Symbol: NASDAQ:RTIX
• CIK: 1100441
• Web: www.rtix.com
• Phone: (877) 343-6832
• Fax: N/A
• Employees: 891
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.16)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-211,640,000.00
• Net Margins: -70.56%
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $308.38 million
• Price / Sales: 0.76
• Cash Flow: $0.30 per share
• Price / Cash Flow: 10.31
• Book Value: $2.89 per share
• Price / Book: 1.09

Miscellaneous

• Outstanding Shares: 74,601,000
• Free Float: N/A
• Market Cap: $234.25 million
• Optionable: Optionable
• Beta: 2.14